Morphine (MOP) antibody and antigen (hapten, BSA/OVA conjugated)
Diagnostic anti-Morphine (MOP) antibodies (anti-Morphine, anti-MOP) and diagnostic hapten-carrier conjugates BSA-Morphine (MOP), OVA-Morphine (MOP), KLH-Morphine (MOP) antigens for Pain MOP detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-237-Ag01 | BSA-Morphine (MOP) | 756 |
GMP-SMT-237-Ag02 | OVA-Morphine (MOP) | 756 |
GMP-SMT-237-Ab01 | Anti-human Morphine (MOP) mouse monoclonal antibody (mAb) | 1953 |
GMP-SMT-237-Ab02 | Anti-human Morphine (MOP) human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-SMT-237-Ag01 |
Product Name | BSA-Morphine (MOP) |
Target/Biomarker | Morphine (MOP) |
Expression platform | Synthetic |
Isotypes | NA |
Bioactivity validation | Morphine (MOP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in MOP level test of Pain () and related syndrome evaluation. |
Tag | NA |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Morphine (MOP) / OVA-Morphine (MOP) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-SMT-237-Ag02 |
Product Name | OVA-Morphine (MOP) |
Target/Biomarker | Morphine (MOP) |
Expression platform | Synthetic |
Isotypes | NA |
Bioactivity validation | Morphine (MOP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in MOP level test of Pain () and related syndrome evaluation. |
Tag | NA |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Morphine (MOP) / OVA-Morphine (MOP) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-SMT-237-Ab01 |
Product Name | Anti-human Morphine (MOP) mouse monoclonal antibody (mAb) |
Target/Biomarker | Morphine (MOP) |
Expression platform | Hybridoma |
Isotypes | Mouse IgG |
Bioactivity validation | Morphine (MOP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in MOP level test of Pain () and related syndrome evaluation. |
Tag | mFc |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Morphine (MOP) / OVA-Morphine (MOP) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-SMT-237-Ab02 |
Product Name | Anti-human Morphine (MOP) human monoclonal antibody (mAb) |
Target/Biomarker | Morphine (MOP) |
Expression platform | Hybridoma |
Isotypes | Mouse IgG |
Bioactivity validation | Morphine (MOP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in MOP level test of Pain () and related syndrome evaluation. |
Tag | mFc |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Morphine (MOP) / OVA-Morphine (MOP) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
1. What is Morphine, and Its Role in In Vitro Diagnostics (IVD)? Morphine, an opium-derived natural alkaloid, serves as an indispensable subject in the realm of in vitro diagnostics (IVD). It is a pharmacologically significant compound known for its potent analgesic properties and widespread clinical use in the management of acute and chronic pain. Within the context of IVD, Morphine assumes a critical role, and our biopharmaceutical company specializes in providing tailored solutions for the precise measurement of Morphine. We accomplish this through a range of dedicated tools, including anti-Morphine antibodies and competitive small-molecule antigens, such as Carrier-coupled antigens, immunogens, hapten-carrier conjugates, BSA-conjugated, and OVA-conjugated forms, meticulously designed for IVD applications. Morphine in Clinical Practice: Morphine, a prototypical opioid, exerts its analgesic effects by binding to specific receptors in the central nervous system. It is commonly administered to patients in various clinical scenarios, including post-surgical pain management, cancer-related pain, and palliative care. Despite its undeniable therapeutic benefits, Morphine also carries the risk of misuse, dependence, and overdose, making accurate monitoring of its levels in patients crucial, which is where IVD plays a pivotal role. IVD Solutions for Morphine Assessment: Our company's specialized products enable the development of diagnostic assays tailored to the quantification and detection of Morphine levels within biological specimens like blood and urine. These assays, integral to the IVD landscape, serve as powerful tools for healthcare practitioners and researchers alike. 2. Significance of Morphine Measurement a. Patient Monitoring: Patients under Morphine therapy necessitate vigilant monitoring to ensure optimal dosage administration. The goal is to maintain pain relief while minimizing potential adverse effects, such as respiratory depression or sedation. Routine Morphine level assessments empower healthcare practitioners to fine-tune treatment regimens, optimizing pain management and patient safety. b. Overdose Mitigation: Due to its potency, Morphine overdose can result in life-threatening complications, most notably respiratory depression. IVD tests for Morphine provide early detection capabilities, facilitating timely interventions to avert overdose incidents. This is especially critical in scenarios where patients may have variable drug responses or when multiple medications are administered concurrently. c. Addiction Management: In cases of opioid addiction or misuse, accurate measurement of Morphine levels aids in gauging addiction severity and guiding appropriate treatment interventions. Quantifying Morphine levels can assist in assessing progress during addiction rehabilitation programs, ensuring patients are on track toward recovery. d. Forensic and Occupational Screening: Morphine measurements are pivotal in forensic investigations, where they can provide crucial insights into recent drug usage histories. In the context of workplace drug testing, detecting Morphine levels can be essential for ensuring employee safety and maintaining a drug-free workplace environment. e. Research Advancements: Within the realm of pharmaceutical research and development, understanding Morphine metabolism and pharmacokinetics is paramount. Accurate IVD tests for Morphine play an instrumental role in assessing drug safety profiles, conducting efficacy studies, and optimizing treatment protocols. In summary, the precise measurement of Morphine is pivotal within the landscape of in vitro diagnostics (IVD). It ensures the safe and efficacious administration of this potent analgesic, aids addiction management, and caters to various clinical and research requisites. Our specialized product portfolio plays a pivotal role in facilitating accurate and sensitive Morphine assessments, addressing the multifaceted needs of healthcare professionals and researchers. As the field of IVD continues to advance, our commitment to providing innovative solutions for Morphine measurement remains unwavering, contributing to improved patient care and clinical outcomes.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.